Celebrating 17 Years of Advancing Biopharma R&D Innovation, Decision Making and Operations

A conference for people at the intersection of science, business & operations…

In an environment of declining revenues and uncertain commercial success, biopharma, device, and R&D companies must continuously optimize their strategy, evaluate their portfolios, improve decision making, reduce risk, and effectively deploy resources. The oncology and immuno-oncology fields face these challenges and more given the shifting paradigms in this disease area. Cambridge Healthtech Institute and the BioPharma Strategy Series present a full week of high-level content, interactive discussions and networking at the 2nd Annual “Strategic and Operational Challenges of Immuno-Oncology Drug Development” (Mon-Tues), a “Decision Analysis & Project Portfolio Management Master Class” (Mon-Tues), 17th Annual “Strategic Resource Management” (Wed-Thurs), and 14th Annual “Portfolio Management” (Thurs-Fri).

Cambridge Healthtech Institute’s annual executive forum brings together R&D executives from the biopharma community to share best practices in project and portfolio management, R&D innovation, decision analysis, forecasting, resource management, and immuno-oncology drug development. Attendees will gain strategic insights and proven tools, methods, and perspectives from a variety of leaders at the intersection of science, business, and operations.